What You Should Know
The Danish Center for AI Innovation (DCAI) and clinical AI lab Corti have launched Corti Models, a governed, model-agnostic infrastructure layer providing European enterprises with sovereign control over AI deployments, data security, and compliance.The platform provides an OpenAI-compatible API supporting sovereign cloud and on-premises environments, allowing organizations to route workloads to leading foundation models without rewriting existing SDK integrations or
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Aily Labs Partners with Google Cloud to Scale AI Decision Intelligence for Pharma and Biotech
What You Should Know
Aily Labs, developer of an AI-native Decision Intelligence platform, announced a strategic partnership with Google Cloud to launch its platform on the Google Cloud Marketplace.The collaboration enables global life sciences, pharmaceutical, and biotech enterprises to procure and deploy Aily’s AI agents directly through existing Google Cloud contracts, counting toward committed cloud spend without additional vendor or compliance reviews.Aily’s decision-ready agents
Read More
Craif Secures $33M to Bring AI-Powered Urine Oncology Diagnostics to the U.S.
What You Should Know
Craif Inc., a bio-AI company developing a non-invasive urine analysis platform for early cancer detection, closed an approximately $33M Series D round (¥5.28 billion), bringing its total capital raised to roughly $88M (¥14.2 billion).The financing was co-led by Granite-Integral (a joint venture between Granite Asia and Integral Corporation) and TAUNS Laboratories, Inc. (one of Japan’s largest rapid diagnostic test manufacturers), with participation from U.S.-based
Read More
Your GLP-1 Prescription Is Table Stakes. Now What?
Virtual clinics are very good at getting GLP-1s into patients' hands fast. That chapter is behind us, and the margins are compressing to prove it.
Leaders like Ro, hims & hers, Calibrate and Found have started building more holistic health solutions, layering in coaching, CGMs, and behavioral support. That is a decent first step. But breadth without depth isn't a moat; it's a feature set. And it’s only a matter of time before feature sets get copied.
Moreover “holistic” by itself begs
Read More
Viome Life Sciences Acquires Circulate Health to Launch Viome Professional Clinical Group
What You Should Know
Viome Life Sciences announced the acquisition of Circulate Health, a developer of outpatient therapeutic plasma exchange (TPE) protocols targeting healthspan extension and chronic disease management.The transaction bridges Viome’s molecular diagnostic, microbiome, and precision nutrition platform with Circulate’s physician-guided outpatient TPE protocols and nationwide network of partner clinics staffed by specialized nurses.Circulate Health Co-Founder and CEO Dr. Brad
Read More
From “Maybe” to Baltic Gods: The Stories Behind Virus Names
Hundreds of new RNA viruses are discovered every year, but every discovery brings an unexpected challenge: what should the new virus be called? While some names describe where a virus was found or which species it infects, others draw inspiration from mythology, language, biology and even heavy metal music.
Among the viruses officially recorded in international genetic sequence databases are Galbūt ("Maybe"), Ūsinis, Barstukas, Pikulas and Patulas, all named by Lithuanian virologist Dr Gytis
Read More
H1 and Novo Nordisk Partner to Advance AI-Driven Clinical Development
What You Should Know
Healthcare data and AI platform H1 announced a strategic partnership with global pharmaceutical leader Novo Nordisk to modernize clinical trial development.Under the agreement, H1 will acquire rights to further advance StudyHub, Novo Nordisk's proprietary digital and AI-enabled platform for clinical trial execution.The collaboration combines H1's global Doctor Graph and AI-ready datasets with Novo Nordisk’s clinical trial operations to optimize protocol design, site
Read More
Inocras Closes $31M for Whole-Genome Bioinformatics Platform
What You Should Know
San Diego-based bioinformatics company Inocras Inc. closed an oversubscribed $31M Series B-3 financing round, bringing its total capital raised to approximately $100M.The funding round was supported by strategic investors NDS Corporation and Aimed Bio Inc., alongside new investors IMM Investment, Korea Investment & Securities, LoftyRock Investment, DT& Investment, Woori Investment & Securities, and Shinhan Securities.Proceeds will fund the U.S. expansion of
Read More
Pharma Is Deploying AI Faster Than It Can Understand Its Risk
A year ago, integrating AI-powered clinical workflow tools could take months of review and planning across disparate teams within a pharmaceutical company's IT, security, and risk teams. Today, with the proliferation of tools that have less than a month of onboarding and can provide immediate value to clinical teams, the way risk is approached has changed. For better or worse, AI capabilities are outpacing the security programs meant to govern them, and many companies are simply assuming risk
Read More
Healing Without Drugs: A Promising Future for Alzheimer’s Patients
Of the medical diagnoses that cause anxiety, sorrow, and despair for patients and their loved ones, Alzheimer’s is near the top of the list. An incurable condition that slowly robs people of memory, identity, and independence, Alzheimer’s puts immense financial and emotional burdens on families.
That may be changing for more than 7 million Americans living with the disease, and the hundreds of thousands more who are newly diagnosed each year. A new wave of scientific and technological
Read More
